That is specualtive of course. Without any concrete information I can't see this as a positive for the company. To me, it appears more a gamble than anything, and gambling has not been a part of this company's current M.O. I am concerned until I hear more information of the logic involved in this request. Listing in my eyes is not the goal, success with Oxycyte is and always should be the main focus. The trials can occur without the split. Furthermore, if there is some company in the background, then why did we sell a bunch of shares to a company listed in the Cayman Islands?
Market Data 
Markets 
AI
